Cargando…

Late-Onset Medullary Thyroid Cancer in a Patient with a Germline RET Codon C634R Mutation

Background: Multiple endocrine neoplasia type 2A (MEN2A) is a rare, hereditary syndrome resulting from a germline mutation in the RET proto-oncogene and characterized primarily by medullary thyroid cancer (MTC), pheochromocytoma (PHEO), and hyperparathyroidism. Types of RET mutation have been associ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Walczyk, Agnieszka, Zgubieński, Kajetan, Chmielewski, Grzegorz, Hińcza-Nowak, Kinga, Kowalik, Artur, Jaskulski, Jarosław, Kowalska, Aldona
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393343/ https://www.ncbi.nlm.nih.gov/pubmed/34441382 http://dx.doi.org/10.3390/diagnostics11081448

Ejemplares similares

Current Knowledge of Germline Genetic Risk Factors for the Development of Non-Medullary Thyroid Cancer
por: Hińcza, Kinga, et al.
Publicado: (2019)

Immune Profiling of Medullary Thyroid Cancer—An Opportunity for Immunotherapy
por: Hińcza-Nowak, Kinga, et al.
Publicado: (2021)

CD276 as a Candidate Target for Immunotherapy in Medullary Thyroid Cancer
por: Hińcza-Nowak, Kinga, et al.
Publicado: (2023)

Germline BRCA1 Mutation Detected in a Multiple Endocrine Neoplasia Type 2 Case With RET Codon 634 Mutation
por: Sarkadi, Balázs, et al.
Publicado: (2019)

Are molecular tests necessary to diagnose NIFTP?
por: Kuchareczko, Artur, et al.
Publicado: (2021)

A PCR-mutagenesis strategy for rapid detection of mutations in codon 634 of the ret proto-oncogene related to MEN 2A.
por: Roqué, María, et al.
Publicado: (2002)

A Novel Somatic Mutation in the RET Proto‐oncogene in Familial Medullary Thyroid Carcinoma with a Germline Codon 768 Mutation
por: Miyauchi, Akira, et al.
Publicado: (1997)

Incidence of the CHEK2 Germline Mutation and Its Impact on Clinicopathological Features, Treatment Responses, and Disease Course in Patients with Papillary Thyroid Carcinoma
por: Gąsior-Perczak, Danuta, et al.
Publicado: (2021)

Preventive Transoral Endoscopic Thyroidectomy by Vestibular Approach in 6-Year-Old Patient with the High-Risk RET C634R Germline Mutation
por: Panaseykin, Yury, et al.
Publicado: (2023)

Does the TT Variant of the rs966423 Polymorphism in DIRC3 Affect the Stage and Clinical Course of Papillary Thyroid Cancer?
por: Hińcza, Kinga, et al.
Publicado: (2020)

The synergy of germline C634Y and V292M RET mutations in a northern Chinese family with multiple endocrine neoplasia type 2A
por: Yang, Zheng, et al.
Publicado: (2020)

Coexisting Germline CHEK2 and Somatic BRAF(V600E) Mutations in Papillary Thyroid Cancer and Their Association with Clinicopathological Features and Disease Course
por: Gąsior-Perczak, Danuta, et al.
Publicado: (2019)

A Korean Family of Familial Medullary Thyroid Cancer with Cys618Ser RET Germline Mutation
por: Jung, Jinhyang, et al.
Publicado: (2010)

A Case of Medullary Thyroid Carcinoma with de novo V804M RET Germline Mutation
por: Choi, Young Sik, et al.
Publicado: (2013)

Predominant RET Germline Mutations in Exons 10, 11, and 16 in Iranian Patients with Hereditary Medullary Thyroid Carcinoma
por: Hedayati, Mehdi, et al.
Publicado: (2011)

MON-562 Retrospective Analysis of Medullary Thyroid Carcinoma: Comparison between Individuals with and without RET Germline Mutation
por: Costa, Cláudia, et al.
Publicado: (2019)

RET codon 618 mutations in Saudi families with multiple endocrine neoplasia Type 2A and familial medullary thyroid carcinoma
por: Qari, Faiza
Publicado: (2013)

A large Chinese pedigree of multiple endocrine neoplasia type 2A with a novel C634Y/D707E germline mutation in RET exon 11
por: Lu, Fanqian, et al.
Publicado: (2017)

Allel RET+3 : T a medullary thyroid cancer
por: Pławski, A, et al.
Publicado: (2011)

Results and Clinical Interpretation of Germline RET Analysis in a Series of Patients with Medullary Thyroid Carcinoma: The Challenge of the Variants of Uncertain Significance
por: Innella, Giovanni, et al.
Publicado: (2020)

Histopathology and immunohistochemistry as prognostic factors for poorly differentiated thyroid cancer in a series of Polish patients
por: Walczyk, Agnieszka, et al.
Publicado: (2020)

Chinese siblings with hereditary medullary thyroid carcinoma caused by RET mutation: implications for RET oncogene detection
por: Huang, Qin, et al.
Publicado: (2020)

Differences in the transcriptome of medullary thyroid cancer regarding the status and type of RET gene mutations
por: Oczko-Wojciechowska, Malgorzata, et al.
Publicado: (2017)

Molecular Basis of Medullary Thyroid Carcinoma: The Role of RET Polymorphisms
por: Ceolin, Lucieli, et al.
Publicado: (2011)

Corrigendum: Differences in the transcriptome of medullary thyroid cancer regarding the status and type of RET gene mutations
por: Oczko-Wojciechowska, Malgorzata, et al.
Publicado: (2017)

Is Male Sex A Prognostic Factor in Papillary Thyroid Cancer?
por: Gajowiec, Aleksandra, et al.
Publicado: (2021)

Unexpected structures formed by the kinase RET C634R mutant extracellular domain suggest potential oncogenic mechanisms in MEN2A
por: Liu, Yixin, et al.
Publicado: (2022)

SAT540 A Case of Simultaneous Medullary Thyroid Cancer (MTC) And Papillary Thyroid Cancer (PTC) In a Patient With Germline RET Mutation
por: Vaghasia, Nishit, et al.
Publicado: (2023)

Clinical characteristics of a large familial cohort with Medullary thyroid cancer and germline Cys618Arg RET mutation in an Israeli multicenter study
por: Rosenblum, Rachel Chava, et al.
Publicado: (2023)

RET mutations in a large indian family with medullary thyroid carcinoma
por: Mahesh, D. M., et al.
Publicado: (2014)

RET mutation heterogeneity in primary advanced medullary thyroid cancers and their metastases
por: Romei, Cristina, et al.
Publicado: (2018)

Modifier Role of Common RET Variants in Sporadic Medullary Thyroid Carcinoma
por: Skalniak, Anna, et al.
Publicado: (2021)

Effect of 3′UTR RET Variants on RET mRNA Secondary Structure and Disease Presentation in Medullary Thyroid Carcinoma
por: Ceolin, Lucieli, et al.
Publicado: (2016)

Higher RET Gene Expression Levels Do Not Represent anAlternative RET Activation Mechanism in Medullary Thyroid Carcinoma
por: Mulè, Chiara, et al.
Publicado: (2021)

Two Germline Missense Mutations at Codons 804 and 806 of the RET Proto‐oncogene in the Same Allele in a Patient with Multiple Endocrine Neoplasia Type 2B without Codon 918 Mutation
por: Miyauchi, Akira, et al.
Publicado: (1999)

Long-term Clinicopathological Features of a Family with Multiple Endocrine Neoplasia Type 2A Caused by C634R RET Gene Mutation
por: Prabhu, Meghana, et al.
Publicado: (2020)

RET Germline Mutations Identified by Exome Sequencing in a Chinese Multiple Endocrine Neoplasia Type 2A/Familial Medullary Thyroid Carcinoma Family
por: Qi, Xiao-Ping, et al.
Publicado: (2011)

Telomeres and telomerase in oncogenesis
por: Trybek, Tomasz, et al.
Publicado: (2020)

RET codon 609 mutations: a contribution for better clinical managing
por: Mian, Caterina, et al.
Publicado: (2012)

The p.G534E variant of HABP2 is not associated with sporadic papillary thyroid carcinoma in a Polish population
por: Kowalik, Artur, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_dmk5d6je8ghmff88d5t11jg6dj